DWJ 1261Alternative Names: DWJ-1261
Latest Information Update: 30 Nov 2016
At a glance
- Originator Daewoong Pharmaceutical
- Class Antithrombotics
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preregistration Thrombosis
Most Recent Events
- 30 Nov 2016 Preregistration for Thrombosis in South Korea (unspecified route)